Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 38.5b

3 Nov 2015 18:02

RNS Number : 4547E
Goldman Sachs & Co.
03 November 2015
 

Ap27

 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN, SACHS & CO.

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 1)

USD ordinary

Date of dealing

02 November 2015

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

622,575 (0.01)

2,028,992 (0.03)

(2) Derivatives (other than options)

0 (0.00)

 0 (0.00)

(3) Options and agreements to purchase/sell

0 (0.00)

 0 (0.00)

Total

622,575 (0.01)

2,028,992 (0.03)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Ap28

 

 

3. DEALINGS (Note 3)

 

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit (Note 4)

Purchase (Loan Partial Return)

2,800

N/A

Purchase (Loan Full Return)

127,803

N/A

Sale (Loan New)

1,852,304

N/A

Sale (Loan New)

2,800

N/A

Purchase (Loan Full Return)

2,800

N/A

Sale (Loan New)

2,800

N/A

Purchase (Loan Full Return)

2,800

N/A

Sale (Loan New)

2,800

N/A

Purchase (Loan Full Return)

2,800

N/A

Purchase (Loan Partial Return)

205,335

N/A

Purchase (Loan Full Return)

1,829,904

N/A

Sale (Loan New)

2,800

N/A

Purchase (Loan Full Return)

2,800

N/A

Sale (Loan New)

2,800

N/A

Purchase (Loan Full Return)

2,800

N/A

Sale (Loan New)

173,160

N/A

Sale (Loan New)

2,800

N/A

Purchase (Loan Full Return)

2,800

N/A

Sale (Loan New)

2,800

N/A

Purchase (Loan Full Return)

2,800

N/A

Sale (Loan New)

2,800

N/A

Purchase (Loan Full Return)

2,800

N/A

Sale (Loan New)

7,086

N/A

Purchase (Loan Full Return)

7,086

N/A

Sale (Loan New)

38,271

N/A

Purchase (Loan Full Return)

38,271

N/A

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(Note 4)

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

Ap29

 

OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached? (Note 8)  YES/NO

 

 

Date of disclosure

03 November 2015

Contact name

Aadithya Rao and Yiannis Bardis

Telephone number

+44(20) 7051 9046 / +44(20) 7774 7107

Name of offeree/offeror with which connected

Pfizer Inc

Nature of connection (Note 9)

Advisor to Offeror

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEEAXFDESXSFFF
Date   Source Headline
13th Nov 20155:08 pmRNSForm 8.3 - Pfizer, Inc.
13th Nov 20155:05 pmRNSForm 8.3 - Pfizer, Inc.
13th Nov 20153:33 pmRNSForm 8.3 - Allergan plc
13th Nov 20153:26 pmRNSForm 8.3 - Pfizer Inc
13th Nov 20153:26 pmRNSForm 8.3 - Pfizer Inc
13th Nov 20153:26 pmRNSForm 8.3 - PFIZER INC
13th Nov 20153:17 pmRNSForm 8.3 - Pfizer Inc.
13th Nov 20153:12 pmRNSForm 8.3 - [PFIZER INC]
13th Nov 20152:59 pmBUSForm 8.3 - Pfizer Inc.
13th Nov 20152:45 pmRNSForm 8.3 - Pfizer Inc
13th Nov 20152:40 pmRNSForm 8.3 - ALLERGAN PLC
13th Nov 20152:37 pmRNSForm 8.3 - Allergan Plc
13th Nov 20151:57 pmRNSForm 8.3 - Allergan plc
13th Nov 201512:10 pmRNSForm 38.5b
13th Nov 201512:07 pmRNSForm 38.5b
13th Nov 201512:05 pmRNSForm 38.5a
13th Nov 201512:03 pmRNSForm 8.1 - [Pfizer Inc]
13th Nov 201511:55 amRNSForm 8.1(a) - Pfizer Inc.
13th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
13th Nov 201511:47 amRNSForm 38.5(a) - Pfizer Inc.
13th Nov 201511:40 amRNSForm 38.5(b) - Pfizer Inc.
13th Nov 201511:05 amRNSRule 38.5 - Pfizer INC
13th Nov 201511:04 amRNSRule 38.5 - Pfizer INC
13th Nov 201511:02 amRNSRule 38.5 - Pfizer INC
13th Nov 20157:00 amRNSForm 8.3 - Pfizer Inc - Replacement
12th Nov 20153:37 pmRNSForm 8.3 - ALLERGAN PLC
12th Nov 20153:30 pmRNSForm 8.3 - Allergan plc
12th Nov 20153:29 pmRNSForm 8.3 - Pfizer Inc
12th Nov 20153:27 pmRNSForm 8.3 - Pfizer Inc
12th Nov 20153:14 pmRNSForm 8.3 - [PFIZER INC]
12th Nov 20153:05 pmRNSForm 8.3 - PFIZER INC
12th Nov 20153:05 pmRNSForm 8.3 - Pfizer, Inc.
12th Nov 20152:58 pmRNSForm 8.3 - Pfizer Inc
12th Nov 20152:53 pmRNSRule 38.5 - Replacement Pfizer INC
12th Nov 20152:44 pmRNSForm 8.3 - Allergan Plc
12th Nov 20152:16 pmRNSForm 38.5(b) - Pfizer Inc Amendment
12th Nov 20151:56 pmRNSForm 8.3 - Allergan plc
12th Nov 201511:56 amRNSForm 38.5a
12th Nov 201511:55 amRNSForm 8.3 - Pfizer, Inc.
12th Nov 201511:54 amRNSForm 8.1 - [Pfizer Inc]
12th Nov 201511:51 amRNSForm 38.5(b) - Pfizer Inc.
12th Nov 201511:49 amRNSForm 38.5(a) - Pfizer Inc
12th Nov 201511:09 amRNSRule 38.5 - Pfizer INC
12th Nov 201511:06 amRNSRule 38.5 - Pfizer INC
11th Nov 20153:33 pmRNSForm 8.3 - Pfizer Inc
11th Nov 20153:19 pmRNSForm 8.3 - [PFIZER INC]
11th Nov 20153:11 pmRNSForm 8.3 - ALLERGAN PLC
11th Nov 20153:09 pmRNSForm 8.3 - PFIZER INC
11th Nov 20153:09 pmRNSForm 8.3 - Pfizer, Inc.
11th Nov 20153:06 pmRNSForm 8.3 - Pfizer Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.